Bayer CropScience Buys Athenix For $365M
Germany-based Bayer CropScience AG has completed its $365 million acquisition of biotechnology company Athenix Corp., a portfolio company of private equity firm Boston Millennia Partners....To view the full article, register now.
Already a subscriber? Click here to view full article